The Vif protein of Human Immunodeficiency Virus Type 1 (HIV-1): Enigmas and Solutions [General Articles]

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|2|221-231

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.2, 2004-01, pp. : 221-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E.   Paterson Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite

Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) Activity

By  

Current Pharmaceutical Design, Vol. 10, Iss. 21, 2004-08 ,pp. : 2643-2648

Bentham Science Publishers

Access to resources Recommend Favorite

Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 62-72

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphisms in the Chemokine and Chemokine Receptors: Impact on Clinical Course and Therapy of the Human Immunodeficiency Virus Type 1 Infection (HIV-1)

By  

Current Medicinal Chemistry, Vol. 14, Iss. 12, 2007-05 ,pp. : 1325-1334

Bentham Science Publishers

Access to resources Recommend Favorite

Dimerization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase as an Antiviral Target

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1879-1894

Bentham Science Publishers

Access to resources Recommend Favorite